Cargando…
Discovery of Leukotriene A4 Hydrolase Inhibitors Using Metabolomics Biased Fragment Crystallography
[Image: see text] We describe a novel fragment library termed fragments of life (FOL) for structure-based drug discovery. The FOL library includes natural small molecules of life, derivatives thereof, and biaryl protein architecture mimetics. The choice of fragments facilitates the interrogation of...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2009
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2722745/ https://www.ncbi.nlm.nih.gov/pubmed/19618939 http://dx.doi.org/10.1021/jm900259h |
_version_ | 1782170336536559616 |
---|---|
author | Davies, Douglas R. Mamat, Bjorn Magnusson, Olafur T. Christensen, Jeff Haraldsson, Magnus H. Mishra, Rama Pease, Brian Hansen, Erik Singh, Jasbir Zembower, David Kim, Hidong Kiselyov, Alex S. Burgin, Alex B. Gurney, Mark E. Stewart, Lance J. |
author_facet | Davies, Douglas R. Mamat, Bjorn Magnusson, Olafur T. Christensen, Jeff Haraldsson, Magnus H. Mishra, Rama Pease, Brian Hansen, Erik Singh, Jasbir Zembower, David Kim, Hidong Kiselyov, Alex S. Burgin, Alex B. Gurney, Mark E. Stewart, Lance J. |
author_sort | Davies, Douglas R. |
collection | PubMed |
description | [Image: see text] We describe a novel fragment library termed fragments of life (FOL) for structure-based drug discovery. The FOL library includes natural small molecules of life, derivatives thereof, and biaryl protein architecture mimetics. The choice of fragments facilitates the interrogation of protein active sites, allosteric binding sites, and protein−protein interaction surfaces for fragment binding. We screened the FOL library against leukotriene A4 hydrolase (LTA4H) by X-ray crystallography. A diverse set of fragments including derivatives of resveratrol, nicotinamide, and indole were identified as efficient ligands for LTA4H. These fragments were elaborated in a small number of synthetic cycles into potent inhibitors of LTA4H representing multiple novel chemotypes for modulating leukotriene biosynthesis. Analysis of the fragment-bound structures also showed that the fragments comprehensively recapitulated key chemical features and binding modes of several reported LTA4H inhibitors. |
format | Text |
id | pubmed-2722745 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-27227452009-08-07 Discovery of Leukotriene A4 Hydrolase Inhibitors Using Metabolomics Biased Fragment Crystallography Davies, Douglas R. Mamat, Bjorn Magnusson, Olafur T. Christensen, Jeff Haraldsson, Magnus H. Mishra, Rama Pease, Brian Hansen, Erik Singh, Jasbir Zembower, David Kim, Hidong Kiselyov, Alex S. Burgin, Alex B. Gurney, Mark E. Stewart, Lance J. J Med Chem [Image: see text] We describe a novel fragment library termed fragments of life (FOL) for structure-based drug discovery. The FOL library includes natural small molecules of life, derivatives thereof, and biaryl protein architecture mimetics. The choice of fragments facilitates the interrogation of protein active sites, allosteric binding sites, and protein−protein interaction surfaces for fragment binding. We screened the FOL library against leukotriene A4 hydrolase (LTA4H) by X-ray crystallography. A diverse set of fragments including derivatives of resveratrol, nicotinamide, and indole were identified as efficient ligands for LTA4H. These fragments were elaborated in a small number of synthetic cycles into potent inhibitors of LTA4H representing multiple novel chemotypes for modulating leukotriene biosynthesis. Analysis of the fragment-bound structures also showed that the fragments comprehensively recapitulated key chemical features and binding modes of several reported LTA4H inhibitors. American Chemical Society 2009-07-20 2009-08-13 /pmc/articles/PMC2722745/ /pubmed/19618939 http://dx.doi.org/10.1021/jm900259h Text en Copyright © 2009 American Chemical Society http://pubs.acs.org This is an open-access article distributed under the ACS AuthorChoice Terms & Conditions. Any use of this article, must conform to the terms of that license which are available at http://pubs.acs.org. |
spellingShingle | Davies, Douglas R. Mamat, Bjorn Magnusson, Olafur T. Christensen, Jeff Haraldsson, Magnus H. Mishra, Rama Pease, Brian Hansen, Erik Singh, Jasbir Zembower, David Kim, Hidong Kiselyov, Alex S. Burgin, Alex B. Gurney, Mark E. Stewart, Lance J. Discovery of Leukotriene A4 Hydrolase Inhibitors Using Metabolomics Biased Fragment Crystallography |
title | Discovery of Leukotriene A4 Hydrolase Inhibitors Using Metabolomics Biased Fragment Crystallography |
title_full | Discovery of Leukotriene A4 Hydrolase Inhibitors Using Metabolomics Biased Fragment Crystallography |
title_fullStr | Discovery of Leukotriene A4 Hydrolase Inhibitors Using Metabolomics Biased Fragment Crystallography |
title_full_unstemmed | Discovery of Leukotriene A4 Hydrolase Inhibitors Using Metabolomics Biased Fragment Crystallography |
title_short | Discovery of Leukotriene A4 Hydrolase Inhibitors Using Metabolomics Biased Fragment Crystallography |
title_sort | discovery of leukotriene a4 hydrolase inhibitors using metabolomics biased fragment crystallography |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2722745/ https://www.ncbi.nlm.nih.gov/pubmed/19618939 http://dx.doi.org/10.1021/jm900259h |
work_keys_str_mv | AT daviesdouglasr discoveryofleukotrienea4hydrolaseinhibitorsusingmetabolomicsbiasedfragmentcrystallography AT mamatbjorn discoveryofleukotrienea4hydrolaseinhibitorsusingmetabolomicsbiasedfragmentcrystallography AT magnussonolafurt discoveryofleukotrienea4hydrolaseinhibitorsusingmetabolomicsbiasedfragmentcrystallography AT christensenjeff discoveryofleukotrienea4hydrolaseinhibitorsusingmetabolomicsbiasedfragmentcrystallography AT haraldssonmagnush discoveryofleukotrienea4hydrolaseinhibitorsusingmetabolomicsbiasedfragmentcrystallography AT mishrarama discoveryofleukotrienea4hydrolaseinhibitorsusingmetabolomicsbiasedfragmentcrystallography AT peasebrian discoveryofleukotrienea4hydrolaseinhibitorsusingmetabolomicsbiasedfragmentcrystallography AT hansenerik discoveryofleukotrienea4hydrolaseinhibitorsusingmetabolomicsbiasedfragmentcrystallography AT singhjasbir discoveryofleukotrienea4hydrolaseinhibitorsusingmetabolomicsbiasedfragmentcrystallography AT zembowerdavid discoveryofleukotrienea4hydrolaseinhibitorsusingmetabolomicsbiasedfragmentcrystallography AT kimhidong discoveryofleukotrienea4hydrolaseinhibitorsusingmetabolomicsbiasedfragmentcrystallography AT kiselyovalexs discoveryofleukotrienea4hydrolaseinhibitorsusingmetabolomicsbiasedfragmentcrystallography AT burginalexb discoveryofleukotrienea4hydrolaseinhibitorsusingmetabolomicsbiasedfragmentcrystallography AT gurneymarke discoveryofleukotrienea4hydrolaseinhibitorsusingmetabolomicsbiasedfragmentcrystallography AT stewartlancej discoveryofleukotrienea4hydrolaseinhibitorsusingmetabolomicsbiasedfragmentcrystallography |